Toradol vs Mobic

Listen to the article instead of reading through it.


When patients are dealing with severe acute pain, certain medications that interrupt the production of substances in the body associated with inflammation and pain can deliver much-needed relief. Toradol and Mobic are two such drugs that are prescribed for this purpose. They both belong to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs), but their effects on the body differ slightly due to their unique properties.

Toradol is primarily used for short-term management of moderate to severe acute pain. It works by inhibiting cyclooxygenase, an enzyme responsible for the formation of prostaglandins which cause inflammation and amplify pain signals in your body.

Mobic, also known as meloxicam, tends to be used more frequently for chronic conditions like rheumatoid arthritis or osteoarthritis because it's considered safer for long-term use. Like Toradol, Mobic works by reducing the production of inflammatory chemicals in your body; however, it does so in a more selective manner which helps reduce some side-effects associated with NSAID use.

What is Toradol?

Ketorolac (the generic name for Toradol) was a significant advancement in the class of non-steroidal anti-inflammatory drugs (NSAIDs). It was first approved by the FDA in 1989. Toradol works by reducing hormones that cause inflammation and pain in the body, effectively providing relief from moderate to severe acute pain. It is typically used short-term due to its potential side effects with prolonged use.

Meloxicam (the generic name for Mobic), also an NSAID, is often prescribed for arthritis-related symptoms such as inflammation, swelling, stiffness, and joint pain. Approved by the FDA in 2000, Mobic inhibits enzymes responsible for producing prostaglandins - substances that contribute to inflammation within tissues and organs.

While both medications are effective at managing pain and inflammation, their usage varies significantly depending on patient need and risk factors associated with long-term NSAID use. It's important to note that neither medication should be used chronically without close medical supervision due to potential adverse effects including gastrointestinal bleeding or kidney damage.

What conditions is Toradol approved to treat?

Toradol is approved for the treatment of various types of pain:

  • Management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. It's most often used short-term (up to 5 days).

Mobic, on the other hand, is indicated for:

  • Relief of the signs and symptoms of osteoarthritis
  • Relief of the signs and symptoms of rheumatoid arthritis
  • For relief from chronic musculoskeletal pain.

How does Toradol help with these illnesses?

Toradol helps to manage inflammation and pain by decreasing the production of prostaglandins, hormone-like substances that mediate pain and inflammation. It does this by inhibiting cyclooxygenase enzymes, which are responsible for prostaglandin synthesis in the body. Prostaglandins play a crucial role in bodily responses like fever, inflammation, and perception of pain. When an injury or disease process triggers their release within tissues, they contribute to symptoms such as swelling (edema), redness (erythema), heat (warmth), and pain. By reducing prostaglandin levels through inhibiting cyclooxygenase enzymes, Toradol can limit these inflammatory responses thus helping patients manage their condition more effectively.

What is Mobic?

Mobic, also known by the generic name Meloxicam, is a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX), an enzyme involved in prostaglandin production. Prostaglandins play key roles in inflammation and pain signaling in the body. By reducing their production, Mobic alleviates symptoms linked to osteoarthritis and rheumatoid arthritis such as inflammation, swelling, stiffness and joint pain.

First approved for use by the FDA in 2000, Mobic does not inhibit COX enzymes as broadly as other NSAIDs like Aspirin do; it has greater affinity for COX-2 than for COX-1 which can make its side-effect profile somewhat different from other NSAIDs. In particular, while it may cause stomach upset or nausea like most NSAIDs do due to their inhibition of protective prostaglandins in the gut lining - these effects are generally less severe with Mobic compared to others like Toradol.

Furthermore unlike opioids or centrally acting analgesics it does not typically lead to sedation nor does it have potential for addiction making it more suitable for long-term management of chronic arthritic conditions. Its differential effect on prostaglandin synthesis can be beneficial especially for patients who cannot tolerate side-effects associated with other "typical" NSAIDS such as Toradol.

What conditions is Mobic approved to treat?

Mobic, also known as meloxicam, is FDA approved for the treatment of:

  • Osteoarthritis
  • Rheumatoid arthritis
  • Juvenile rheumatoid arthritis in children aged two years and older

It's an NSAID that works by reducing hormones which cause inflammation and pain in the body. It can be a crucial part of managing these conditions to improve quality of life.

How does Mobic help with these illnesses?

Mobic, also known as meloxicam, is a nonsteroidal anti-inflammatory drug (NSAID) that works by reducing the levels of prostaglandins, chemicals responsible for pain and inflammation in the body. It does this by inhibiting cyclooxygenase enzymes; however, it specifically acts on COX-2 enzyme more than COX-1. This selective inhibition results in less gastrointestinal side effects compared to other NSAIDs like Toradol (ketorolac), which are not selective.

The therapeutic effect of Mobic extends beyond pain relief. Its action against inflammation makes it beneficial for conditions such as osteoarthritis and rheumatoid arthritis. Even though both Mobic and Toradol can be used for short-term management of moderate to severe acute pain that requires analgesia at the opioid level, Mobic's safer gastric profile allows its use in chronic conditions requiring long-term NSAID therapy.

How effective are both Toradol and Mobic?

Both ketorolac (Toradol) and meloxicam (Mobic) are nonsteroidal anti-inflammatory drugs (NSAIDs), widely used to manage moderate to severe pain, especially following surgery or injury. Approved by the FDA in 1989 and 2000 respectively, they have a well-documented history of efficacy and safety. However, their mechanisms differ slightly due to their belonging to different subclasses within the NSAIDs group; ketorolac is a pyrroziline carboxylic acid derivative while meloxicam is an enolic acid derivative.

Ketorolac has been found highly effective for short-term management of moderate-to-severe acute pain where opioid level analgesia is required. A study conducted in 2016 confirmed its effectiveness as an alternative to opioids for postoperative pain control after spinal surgery. Meloxicam also effectively reduces inflammation and pain but it's primarily indicated for chronic conditions like osteoarthritis and rheumatoid arthritis rather than acute surgical or injury-related pain.

A meta-analysis review done on Ketorolac in 2012 showed that while very effective at controlling severe levels of acute pain, care must be taken due to its potential renal side effects when given at high doses or over extended periods. The optimal dose appears to be around 10 mg every four-six hours not exceeding five days.

Meloxicam’s review performed in 1997 revealed good tolerability with fewer gastrointestinal side effects compared with other NSAIDs which makes it suitable for long term use associated with chronic inflammatory diseases. It also has a longer half-life allowing once daily dosing which improves patient compliance.

While both medications are considered first-line treatments when NSAID therapy is appropriate, your healthcare provider will make the choice between them based on your specific circumstances such as type and duration of your condition along with other individual factors like age, concomitant medication use among others.

abstract image of a researcher studying a bottle of drug.

At what dose is Toradol typically prescribed?

Oral dosages of Toradol typically range from 10–40 mg/day, but studies have shown that a single dose of 10 mg is sufficient for relieving moderate to severe acute pain in most adults. Adolescents aged 17 or older may be started on a lower dose of 10mg every 4-6 hours as needed. The dosage can be adjusted based on the individual response and tolerance. However, it should not exceed five days due to an increased risk of serious adverse effects. On the other hand, Mobic is usually prescribed at doses ranging from 7.5-15 mg/day for treating osteoarthritis and rheumatoid arthritis in adults while children over two years old are given a dose according to their body weight for juvenile rheumatoid arthritis treatment. In either population, the maximum dosage that should not be exceeded is 15 mg/day.

At what dose is Mobic typically prescribed?

Mobic (meloxicam) treatment typically begins with a dosage of 7.5 mg/day, which can be taken as a single dose each day. If necessary, and under the guidance of your healthcare provider, the daily dosage can be increased to 15 mg/day, again administered in a single dose. It is important not to exceed this maximum dosage without medical advice due to potential risks associated with higher doses. For optimal results and safety monitoring, regular follow-up appointments should be scheduled if there's no response or insufficient relief from symptoms after several weeks on the initial 7.5 mg/day regimen.

What are the most common side effects for Toradol?

Notable side effects of Toradol and Mobic are quite different due to their individual properties. Some common adverse reactions caused by Toradol include:

  • Headache
  • Dizziness, drowsiness
  • Upset stomach, nausea, vomiting
  • Diarrhea or constipation
  • Sweating
  • Dry mouth

On the other hand, Mobic can cause:

  • Stomach upset such as heartburn/indigestion, nausea,
  • Diarrhea or constipation

It's crucial to seek medical help if any of these symptoms persist or worsen over time.

abstract image of a patient experiencing side effect

Are there any potential serious side effects for Toradol?

Although Toradol and Mobic are both nonsteroidal anti-inflammatory drugs (NSAIDs) used to relieve pain, they can have different side effects. For Toradol, watch for any signs of:

  • Severe stomach or intestinal problems: This includes bleeding or perforation which may manifest as abdominal pain that doesn't go away, black/tarry stools, vomit that looks like coffee grounds.
  • Rare but serious kidney problems: Symptoms include changes in the amount of urine, sudden weight gain due to fluid retention.
  • Allergic reactions: Rash, itching/swelling (especially of the face/tongue/throat), severe dizziness or trouble breathing could indicate a serious allergic reaction to this medication.

On the other hand with Mobic you should be aware of:

  • Signs of heart attack or stroke: Chest/jaw/left arm pain; weakness on one side of your body; slurred speech; sudden vision changes.
  • High blood pressure symptoms: Severe headache, pounding in your neck/ears
  • Liver disease symptoms: Nausea/vomiting that doesn't stop; loss of appetite; stomach/abdominal pain; yellowing eyes/skin; dark urine.

Remember these lists aren't exhaustive and if you experience any unexplained symptoms it's best to consult with a healthcare professional.

What are the most common side effects for Mobic?

Some potential side effects of Mobic (Meloxicam) may include:

  • Upset stomach, nausea, diarrhea or constipation
  • Dizziness or headache
  • Dry mouth, sore throat
  • Increased blood pressure
  • Mild itching or rash
  • Ringing in the ears
  • Fluid retention and swelling While these are some common side effects, it is important to remember that individuals may react differently to medications. Always consult with your healthcare provider for any concerns about a medicine's potential side effects.

Are there any potential serious side effects for Mobic?

While Mobic is typically well-tolerated, it's important to be aware of potential serious side effects. These can include:

  • Signs of an allergic reaction such as hives; difficulty breathing; or swelling of the face, lips, tongue, or throat
  • Chest pain spreading to your jaw or shoulder
  • Sudden weakness on one side of your body
  • Slurred speech or problems with vision or balance
  • Shortness of breath even with mild exertion
  • Swelling in your hands and feet
  • Unusual weight gain

If you experience any of these adverse reactions while taking Mobic, seek immediate medical attention.

Contraindications for Toradol and Mobic?

Both Toradol and Mobic, like most other nonsteroidal anti-inflammatory drugs (NSAIDs), may heighten your risk of serious heart or circulation problems, including heart attack or stroke. If you notice chest pain, weakness, shortness of breath or slurred speech while taking these medications, please seek immediate medical attention.

Neither Toradol nor Mobic can be taken if you are undergoing treatment for perioperative pain in the setting of coronary artery bypass graft (CABG) surgery. Always inform your doctor about all the medications you are currently taking; certain drugs will require a specific period to clear from your system to prevent dangerous interactions with Toradol and Mobic.

Both these NSAIDs could also increase your risk of severe stomach or intestines issues such as bleeding or perforation. Elderly patients and those who have previously had ulcers or gastrointestinal bleeding are at higher risk.

How much do Toradol and Mobic cost?

For the brand name versions of these drugs:

  • The price for 30 tablets of Mobic (15 mg) averages around $150, which works out to approximately $5 per day.
  • The price for 6 injections of Toradol (30mg/mL) is about $80, working out to around $13.33 per injection.

This makes Toradol significantly more expensive on a per-dose basis if you're comparing it directly with Mobic. However, cost shouldn't be the primary deciding factor in choosing between these two medications; their respective efficacies and side effect profiles should also be considered.

As far as generic equivalents go:

  • Meloxicam (generic Mobic), costs substantially less than its branded counterpart: A pack of 30 tablets at a dosage strength of 15mg can range from just under $0.40 up to slightly over a dollar per day.
  • Ketorolac Tromethamine (generic Toradol), though still pricier than meloxicam on average, does come cheaper than branded Toradol: At most pharmacies, each injection can cost anywhere between $2 - $7 depending upon insurance coverage and whether any discounts or coupons are applied. Please remember that this medication tends to be used short-term due to risk factors associated with longer use.

Popularity of Toradol and Mobic

Ketorolac, in both its generic form and the brand name Toradol, is a potent nonsteroidal anti-inflammatory drug (NSAID) mainly used for short-term management of moderate to severe acute pain that would otherwise require opioids. It was prescribed to approximately 1 million people in the US in 2020. Despite being less prevalent than other NSAIDs due to its potential serious side effects — primarily gastrointestinal bleeding and kidney damage — it remains a valuable tool for physicians looking to manage acute pain without resorting to opioids.

On the other hand, meloxicam or Mobic is another NSAID but with a longer half-life allowing once daily dosing. In the USA, meloxicam was prescribed over 20 million times during the same period of time. Meloxicam accounts for about 10% of all NSAID prescriptions across America and has seen a steady increase since its introduction in late 2000s due to its improved safety profile over traditional NSAIDs like ibuprofen or naproxen while providing similar efficacy.


Both Toradol (ketorolac) and Mobic (meloxicam) have a long-standing track record in managing moderate to severe pain, particularly following surgery. They are both nonsteroidal anti-inflammatory drugs (NSAIDs), which work by reducing the production of prostaglandins, substances that cause inflammation, pain and fever in the body. While they have similar mechanisms of action, there are crucial differences between them.

Toradol is typically given for short-term use due to its potential side effects on kidneys and gastrointestinal tract when used over an extended period. It has powerful analgesic properties comparable to morphine but without any narcotic effect or addiction risk.

On the other hand, Mobic is often prescribed for chronic conditions such as arthritis because it can be taken safely over longer periods with lesser renal side effects compared to Toradol. However, like all NSAIDs it also carries a risk of gastrointestinal bleeding especially with prolonged use.

Both medications come in generic forms providing cost savings for patients who pay out-of-pocket. Both may require some time before their full effect becomes noticeable.

Regarding their safety profile, both medications need careful monitoring because of potential heart risks tied with NSAID category along with previously mentioned renal and gastric concerns. The choice between these two drugs should be made in consultation with your physician taking into account individual health circumstances and requirements.